Cargando…
Progress and trends in the development of therapies for Hutchinson–Gilford progeria syndrome
Hutchinson–Gilford progeria syndrome (HGPS) is an autosomal‐dominant genetic disease that leads to accelerated aging and often premature death caused by cardiovascular complications. Till now clinical management of HGPS has largely relied on the treatment of manifestations and on the prevention of s...
Autores principales: | Lai, Wing‐Fu, Wong, Wing‐Tak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370734/ https://www.ncbi.nlm.nih.gov/pubmed/32596971 http://dx.doi.org/10.1111/acel.13175 |
Ejemplares similares
-
Hutchinson-Gilford progeria syndrome
por: Bhukya, Amar Singh, et al.
Publicado: (2015) -
Metabolic Dysfunction in Hutchinson–Gilford Progeria Syndrome
por: Kreienkamp, Ray, et al.
Publicado: (2020) -
Ocular manifestations in the Hutchinson-Gilford progeria syndrome
por: Chandravanshi, Shivcharan L, et al.
Publicado: (2011) -
Isoprenylcysteine Carboxylmethyltransferase-Based
Therapy for Hutchinson–Gilford Progeria Syndrome
por: Marcos-Ramiro, Beatriz, et al.
Publicado: (2021) -
Hutchinson–Gilford Progeria Syndrome: Clinical and Molecular Characterization
por: Pachajoa, Harry, et al.
Publicado: (2020)